---
title: "Stoke Therapeutics General Counsel Jonathan Allan sells $43,638.15 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290242371.md"
description: "Stoke Therapeutics General Counsel Jonathan Allan sold 1,457 common shares on June 16, 2026, at $29.95 per share, totaling approximately $43,638. The transaction left him with a holding of 18,086 shares."
datetime: "2026-06-18T20:19:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290242371.md)
  - [en](https://longbridge.com/en/news/290242371.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290242371.md)
---

# Stoke Therapeutics General Counsel Jonathan Allan sells $43,638.15 in common shares

-   Stoke Therapeutics General Counsel, Corporate Secretary Jonathan Allan sold 1,457 common shares on June 16, 2026 at USD 29.95. \* Allan held 18,086 shares following the sale. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001966716-26-000010), on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [STOK.US](https://longbridge.com/en/quote/STOK.US.md)

## Related News & Research

- [Stoke Therapeutics schedules webcast, call on Q2 business and financial update](https://longbridge.com/en/news/293968659.md)
- [Stoke Therapeutics completes enrollment in Phase 3 EMPEROR trial of Dravet drug zorevunersen](https://longbridge.com/en/news/291279117.md)
- [Virtuix COO David Allan reports sale of 220,821 shares worth $395,269.59](https://longbridge.com/en/news/294437623.md)
- [Unusual Machines CEO agrees to forgo salary for performance warrants struck at $25 a share](https://longbridge.com/en/news/294106687.md)
- [Vivos President Brad Weeks acquires $4,600 of common shares](https://longbridge.com/en/news/293512872.md)